Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.

about

Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response.

P2860

Q47737905-64FEAB57-A300-4010-8CA8-B23BA9D8C58C

P2860

Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.

Item

http://www.wikidata.org/entity/Q38971561

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.

@en

type

Item

label

Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.

@en

prefLabel

Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.

@en

P1433

P1476

Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.

@en

P2093

Johannes A Langendijk

http://www.w3.org/2001/XMLSchema#string

Roel J H M Steenbakkers

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus and survival of patients with oropharyngeal cancer.

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy

The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature

Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

P304

161-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-43580-0_12

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27699537

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy